Baidu
map

J AFFECT DISORDERS:常吃西红柿抑郁症减半

2012-12-12 J AFFECT DISORDERS J AFFECT DISORDERS

  据英国《每日邮报》12月4日报道,《情感紊乱杂志》刊登中日科学家共同完成的一项新研究发现,每周吃几次西红柿可以使罹患抑郁症危险降低一半。   据统计,超过20%的人在一生的某段时间会发生抑郁,女性抑郁症发病率比男性更高。老年人群抑郁症发病率也相对较高,其原因是健康状况一日不如一日,亲人离世以及孤独等。   研究人员表示,西红柿富含的多种抗氧化成分具有抗击多种疾病功效。其中番茄红素有助于降低

  据英国《每日邮报》12月4日报道,《情感紊乱杂志》刊登中日科学家共同完成的一项新研究发现,每周吃几次西红柿可以使罹患抑郁症危险降低一半。

  据统计,超过20%的人在一生的某段时间会发生抑郁,女性抑郁症发病率比男性更高。老年人群抑郁症发病率也相对较高,其原因是健康状况一日不如一日,亲人离世以及孤独等。

  研究人员表示,西红柿富含的多种抗氧化成分具有抗击多种疾病功效。其中番茄红素有助于降低前列腺癌和心脏病危险。多项早期研究认为,番茄红素与心理健康和身体健康关系密切,其机理是番茄红素可降低氧化压力,防止健康大脑细胞受损。

  为了进一步探索番茄红素与心理健康的关系,日本东北大学博士天津医科大学教授牛凯军及其同事对多项早期相关研究进行了梳理分析。研究涉及近1000名年龄至少为70岁的女性参试者。研究人员调查了参试者的心理健康病历与饮食习惯之间的关联性。结果发现,与每周吃西红柿不到1次的人相比,每周吃西红柿2—6次的人罹患抑郁症的危险降低46%。每天吃西红柿可以使抑郁症危险降低52%。但是研究发现,卷心菜、胡萝卜、洋葱和南瓜等健康果蔬却没有这种奇的特抗抑郁功效。

  研究人员表示,尽管目前尚无法确信番茄红素是否直接影响到心理健康,但是新研究结果的确表明,经常吃西红柿对抑郁症具有明显的预防作用。



Background
Enhanced oxidative stress or defective anti-oxidant defenses are related to the pathogenesis of depressive symptoms. Lycopene is the most powerful antioxidant amongst the carotenoids. The aim of this study was to investigate the relationship between different vegetables, including tomatoes/tomato products (a major source of lycopene), and depressive symptoms in a community-based elderly population.
Methods
We analyzed a cross-sectional survey including 986 community-dwelling elderly Japanese individuals aged 70 years and older. Dietary intake was assessed using a valid self-administered diet-history questionnaire, and depressive symptoms were evaluated using the 30-item Geriatric Depression Scale with 2 cut-off points: 11 (mild and severe) and 14 (severe) or use of anti-depressive agents.
Results
The prevalence of mild and severe and severe depressive symptoms was 34.9% and 20.2%, respectively. After adjustments for potentially confounding factors, the odds ratios of having mild and severe depressive symptoms by increasing levels of tomatoes/tomato products were 1.00, 0.54, and 0.48 (p for trend <0.01). Similar relationships were also observed in the case of severe depressive symptoms. In contrast, no relationship was observed between intake of other kinds of vegetables and depressive symptoms.
Limitations
This is a cross-sectional study, and not for making a clinical diagnosis of depressive episodes.
Conclusions
This study demonstrated that a tomato-rich diet is independently related to lower prevalence of depressive symptoms. These results suggest that a tomato-rich diet may have a beneficial effect on the prevention of depressive symptoms. Further studies are needed to confirm these findings.

抑郁症相关的拓展阅读:
    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1784363, encodeId=9b071e84363e3, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Sep 27 07:55:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738098, encodeId=478d1e380989f, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Thu Jun 13 04:55:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878052, encodeId=c39918e8052e0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Dec 13 23:55:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011790, encodeId=75652011e9020, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 15 02:55:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077655, encodeId=990520e76551a, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 03 16:55:00 CST 2013, time=2013-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779407, encodeId=ddc91e79407c9, content=<a href='/topic/show?id=48dc20680a' target=_blank style='color:#2F92EE;'>#Affect#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2068, encryptionId=48dc20680a, topicName=Affect)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sun Oct 27 13:55:00 CST 2013, time=2013-10-27, status=1, ipAttribution=)]
    2013-09-27 cmsvly
  2. [GetPortalCommentsPageByObjectIdResponse(id=1784363, encodeId=9b071e84363e3, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Sep 27 07:55:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738098, encodeId=478d1e380989f, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Thu Jun 13 04:55:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878052, encodeId=c39918e8052e0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Dec 13 23:55:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011790, encodeId=75652011e9020, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 15 02:55:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077655, encodeId=990520e76551a, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 03 16:55:00 CST 2013, time=2013-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779407, encodeId=ddc91e79407c9, content=<a href='/topic/show?id=48dc20680a' target=_blank style='color:#2F92EE;'>#Affect#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2068, encryptionId=48dc20680a, topicName=Affect)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sun Oct 27 13:55:00 CST 2013, time=2013-10-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1784363, encodeId=9b071e84363e3, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Sep 27 07:55:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738098, encodeId=478d1e380989f, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Thu Jun 13 04:55:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878052, encodeId=c39918e8052e0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Dec 13 23:55:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011790, encodeId=75652011e9020, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 15 02:55:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077655, encodeId=990520e76551a, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 03 16:55:00 CST 2013, time=2013-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779407, encodeId=ddc91e79407c9, content=<a href='/topic/show?id=48dc20680a' target=_blank style='color:#2F92EE;'>#Affect#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2068, encryptionId=48dc20680a, topicName=Affect)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sun Oct 27 13:55:00 CST 2013, time=2013-10-27, status=1, ipAttribution=)]
    2012-12-13 anminleiryan
  4. [GetPortalCommentsPageByObjectIdResponse(id=1784363, encodeId=9b071e84363e3, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Sep 27 07:55:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738098, encodeId=478d1e380989f, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Thu Jun 13 04:55:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878052, encodeId=c39918e8052e0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Dec 13 23:55:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011790, encodeId=75652011e9020, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 15 02:55:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077655, encodeId=990520e76551a, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 03 16:55:00 CST 2013, time=2013-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779407, encodeId=ddc91e79407c9, content=<a href='/topic/show?id=48dc20680a' target=_blank style='color:#2F92EE;'>#Affect#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2068, encryptionId=48dc20680a, topicName=Affect)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sun Oct 27 13:55:00 CST 2013, time=2013-10-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1784363, encodeId=9b071e84363e3, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Sep 27 07:55:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738098, encodeId=478d1e380989f, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Thu Jun 13 04:55:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878052, encodeId=c39918e8052e0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Dec 13 23:55:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011790, encodeId=75652011e9020, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 15 02:55:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077655, encodeId=990520e76551a, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 03 16:55:00 CST 2013, time=2013-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779407, encodeId=ddc91e79407c9, content=<a href='/topic/show?id=48dc20680a' target=_blank style='color:#2F92EE;'>#Affect#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2068, encryptionId=48dc20680a, topicName=Affect)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sun Oct 27 13:55:00 CST 2013, time=2013-10-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1784363, encodeId=9b071e84363e3, content=<a href='/topic/show?id=a727600194' target=_blank style='color:#2F92EE;'>#Disord#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6001, encryptionId=a727600194, topicName=Disord)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Fri Sep 27 07:55:00 CST 2013, time=2013-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1738098, encodeId=478d1e380989f, content=<a href='/topic/show?id=e10b600329' target=_blank style='color:#2F92EE;'>#disorders#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6003, encryptionId=e10b600329, topicName=disorders)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efbf34357637, createdName=ms2186806800017884, createdTime=Thu Jun 13 04:55:00 CST 2013, time=2013-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878052, encodeId=c39918e8052e0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Thu Dec 13 23:55:00 CST 2012, time=2012-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011790, encodeId=75652011e9020, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sat Dec 15 02:55:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077655, encodeId=990520e76551a, content=<a href='/topic/show?id=67cc600242' target=_blank style='color:#2F92EE;'>#disorder#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6002, encryptionId=67cc600242, topicName=disorder)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Sep 03 16:55:00 CST 2013, time=2013-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779407, encodeId=ddc91e79407c9, content=<a href='/topic/show?id=48dc20680a' target=_blank style='color:#2F92EE;'>#Affect#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2068, encryptionId=48dc20680a, topicName=Affect)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=365d170, createdName=chenwq08, createdTime=Sun Oct 27 13:55:00 CST 2013, time=2013-10-27, status=1, ipAttribution=)]
    2013-10-27 chenwq08

相关资讯

Lancet:大多数抑郁症患者遭受歧视

    近日在线发表于《柳叶刀》的一项研究显示,大多数抑郁症患者报告受到与他们的精神疾病相关的歧视。   根据英国伦敦国王学院精神病学研究所的研究者进行的一项研究,79%的抑郁患者报告在至少一个生活领域曾受到某种形式的歧视。   “我们的发现显示,与抑郁相关的歧视普遍存在,几乎成为抑郁患者进行积极的社会生活并拥有公平工作机会的障碍。”第一研究者Graham Th

PNAS:原钙粘蛋白家族在抑郁症发病中起关键作用

  最新一期的世界顶级学术期刊《美国国家科学院(PNAS)》发布了上海交大研究团队一项重要成果。上海交大系统生物医学研究院教授吴强的科研团队发现一种特殊蛋白质调控机理,阐明了原钙粘蛋白家族在大脑中细胞特异性表达的分子机制。这一研究成果对科学家破解人类基因组的编码调控机制,以及破解精神疾病发病机理将产生深远影响。   上海交大系统生物医学研究院教授吴强5日介绍,人脑含有上千亿个不同的神经细胞,每个

J Clin Psychiatry:衡量抑郁缓解的更好的指标

       近日,一篇刊表于《临床精神病学杂志》[J Clin Psychiatry.  2012; 73(9):1262-3 ]的文章中,就科研人员与抑郁症患者对症状“缓解”定义的不一致性这一问题展开探讨。        抑郁的缓解通常定义为症状评定量表(例如

J Nutr:维生素B1缺乏与抑郁症密切相关

       近日,国际学术刊物《营养杂志》(J Nutr.2012Nov21.)在线发表了中科院上海生科院营养科学研究所柯尊记研究组和林旭研究组合作的最新研究成果。该研究揭示了在中国中老年人群中维生素B1缺乏与抑郁症密切相关。        维生素B1即硫胺素,在人体内以游离硫胺素、硫胺素单磷酸酯(TMP)

世界精神卫生日 世卫组织呼吁消除歧视

  10月10日是世界精神卫生日,世界卫生组织(世卫组织)呼吁消除对抑郁症和其它精神疾患的歧视,并呼吁向所有需要的人提供更好的治疗机会。   克服歧视问题,增强治疗机会   全球共有3.5亿多人患抑郁症。抑郁症是一种精神疾患,患者无法正常生活。由于抑郁症患者往往仍遭歧视,许多患者不愿承认自己患病且不愿寻求治疗。   抑郁症有别于通常的情绪波动。抑郁症患者连续两周或两周以上心情郁闷,无法正常工

PLoS One:TG2的识别或有助于开发新型抑郁症疗法

近日,一项刊登在国际杂志PLoS One上的研究报告指出,将两种分子(一种分子在抑郁症中水平降低,一种分子在使用抗抑郁症药物后水平升高)结合起来,或可以产生出治疗抑郁症的新药。血清素(Serotonin)是一种神经递质,其可以使大脑细胞之间互相交流以及产生脑源性神经生长因子(BDNF),BDNF是一种大脑营养因子可以补充神经细胞之间的连接性。流行的抗抑郁药比如百优解,可以增加血清素的水平,其也可以

Baidu
map
Baidu
map
Baidu
map